Literature DB >> 1265093

Analgesia and hyperractivity following morphine microinjection into mouse brain.

H E Criswell.   

Abstract

Analgesia and a paradoxical hyperreactivity to stimuli of sudden onset have recently been reported following the microinjection of morphine into the periacqueductal gray matter of rats. These effects have not been systematically investigated in other species. In the present study, both analgesia and hyperreactivity were observed as dose dependent effects of morphine microinjection into the periacqueductal gray matter of several strains of mice. Analgesia alone was produced by low doses of morphine while at higher doses analgesia was accompanied by hyperreactivity. Strain differences were noted with B6D2F1 mice being more susceptible to the hyperreactivity following morphine than BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265093     DOI: 10.1016/0091-3057(76)90170-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  Imaging chronic daily headache.

Authors:  Sheena K Aurora
Journal:  Curr Pain Headache Rep       Date:  2003-06

Review 2.  Opioid receptors and pain.

Authors:  R Dirksen
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

3.  CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception.

Authors:  Jennie L Conroy; Julia W Nalwalk; James G Phillips; Lindsay B Hough
Journal:  Brain Res       Date:  2013-01-05       Impact factor: 3.252

4.  Changes in response properties of rostral ventromedial medulla neurons during prolonged inflammation: modulation by neurokinin-1 receptors.

Authors:  S G Khasabov; T S Brink; M Schupp; J Noack; D A Simone
Journal:  Neuroscience       Date:  2012-08-20       Impact factor: 3.590

5.  Naloxone injections into the periaqueductal grey area and arcuate nucleus block analgesia in defeated mice.

Authors:  K A Miczek; M L Thompson; L Shuster
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.